ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesN40.0

N40.0

Billable

Benign prostatic hyperplasia without lower urinary tract symptoms

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/18/2025

Code Description

ICD-10 N40.0 is a billable code used to indicate a diagnosis of benign prostatic hyperplasia without lower urinary tract symptoms.

Key Diagnostic Point:

Benign prostatic hyperplasia (BPH) is a common condition characterized by the enlargement of the prostate gland, which occurs as men age. This condition is non-cancerous and is distinct from prostate cancer and prostatitis. In many cases, BPH does not present with lower urinary tract symptoms (LUTS), which can include urinary frequency, urgency, and nocturia. The absence of these symptoms can make diagnosis challenging, as many men may not seek medical attention until symptoms develop. BPH is thought to be related to hormonal changes, particularly the influence of dihydrotestosterone (DHT) on prostate tissue. Diagnosis typically involves a combination of patient history, physical examination, and laboratory tests, including prostate-specific antigen (PSA) levels, which can help rule out prostate cancer. Treatment options vary from watchful waiting to pharmacological interventions and surgical procedures, depending on the severity of symptoms and the impact on the patient's quality of life.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating BPH from other prostate disorders such as prostatitis and prostate cancer.
  • Understanding the absence of LUTS in the context of BPH.
  • Interpreting PSA levels and their implications for diagnosis.
  • Navigating treatment options and their documentation requirements.

Audit Risk Factors

  • Inadequate documentation of the absence of LUTS.
  • Misinterpretation of PSA levels leading to incorrect coding.
  • Failure to document follow-up care or monitoring.
  • Inconsistent use of terminology regarding prostate disorders.

Specialty Focus

Medical Specialties

Urology

Documentation Requirements

Detailed patient history, physical examination findings, PSA levels, and any imaging studies.

Common Clinical Scenarios

Routine evaluations for prostate health, monitoring of PSA levels, and management of BPH without symptoms.

Billing Considerations

Urologists must ensure that documentation clearly states the absence of LUTS to support the use of N40.0.

Primary Care

Documentation Requirements

Comprehensive patient history, including any urinary symptoms, and results of PSA tests.

Common Clinical Scenarios

Annual wellness visits where prostate health is assessed, and discussions about BPH are held.

Billing Considerations

Primary care providers should document any patient concerns regarding prostate health, even in the absence of symptoms.

Coding Guidelines

Inclusion Criteria

Use N40.0 When
  • According to ICD
  • 10 guidelines, N40
  • 0 should be used when there is a confirmed diagnosis of benign prostatic hyperplasia without any associated lower urinary tract symptoms
  • Coders must ensure that documentation supports the diagnosis and that no other prostate conditions are present

Exclusion Criteria

Do NOT use N40.0 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

76857CPT Code

Ultrasound, transrectal, prostate

Clinical Scenario

Used to evaluate prostate size and rule out malignancy in patients with elevated PSA levels.

Documentation Requirements

Document the indication for the ultrasound and findings.

Specialty Considerations

Urologists should ensure that the ultrasound results are clearly linked to the diagnosis of BPH.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of prostate disorders, including the differentiation between BPH with and without LUTS. This specificity enhances data accuracy and improves patient care management.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of prostate disorders, including the differentiation between BPH with and without LUTS. This specificity enhances data accuracy and improves patient care management.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of prostate disorders, including the differentiation between BPH with and without LUTS. This specificity enhances data accuracy and improves patient care management.

Resources

Clinical References

  • •
    American Urological Association Guidelines

Coding & Billing References

  • •
    American Urological Association Guidelines

Frequently Asked Questions

What is the difference between BPH and prostatitis?

BPH is a non-cancerous enlargement of the prostate gland, while prostatitis refers to inflammation of the prostate, which can be acute or chronic. BPH typically does not present with symptoms, whereas prostatitis often does.